To view or add a comment, sign in Access To Naloxone Improves, But Some Pharmacies Slow To Stock Doses Drug Topics (6/30, Nowosielski) reports that according to a study published in JAPhA, since naloxone was approved for over-the-counter sale, availability and out-of-pocket (OOP) patient costs have improved significantly. However, when compared with their retail industry counterparts, independent pharmacies demonstrate a significant need to boost naloxone access and decrease OOP costs for their patient populations. The article quotes the studys authors saying, Over the past 25 years, naloxone has emerged as a critical lifesaving overdose antidote
The award will be announced from Swedens Karolinska Institute at around 3:00 PM
Using aortic rings, it was reported that the ASX vasorelaxation effect was NO-dependent, at the low concentration, and NO-independent, at the high dose [34]
What I Tell My Patients, Family and Friends About Menopause and Hunger
Upon examination, it was reported that the corticosteroid appeared to significantly worsen the muscle damage in the murine models